{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T08:49:41Z","timestamp":1749199781024},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,7]]},"DOI":"10.7759\/cureus.34742","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T20:07:47Z","timestamp":1675800467000},"source":"Crossref","is-referenced-by-count":3,"title":["Malignant Melanoma in Older Adults: Different Patient or Different Disease?"],"prefix":"10.7759","author":[{"given":"Daniel C","family":"Sasson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T","family":"Smetona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassmin","family":"Parsaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Papageorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Ariyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Olino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Clune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch CM","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald JE, et al.. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001, 19:3622-34. 10.1200\/JCO.2001.19.16.3622","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.961426","article-title":"Malignant melanoma in elderly patients: biological, surgical and medical issues","volume":"15","author":"Russo AE","year":"2015","unstructured":"Russo AE, Ferra\u00f9 F, Antonelli G, Priolo D, McCubrey JA, Libra M. Malignant melanoma in elderly patients: biological, surgical and medical issues. Expert Rev Anticancer Ther. 2015, 15:101-8. 10.1586\/14737140.2015.961426","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.1.100","article-title":"Malignant melanoma in the elderly","volume":"5","author":"Cohen HJ","year":"1987","unstructured":"Cohen HJ, Cox E, Manton K, Woodbury M. Malignant melanoma in the elderly. J Clin Oncol. 1987, 5:100-6. 10.1200\/JCO.1987.5.1.100","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3464-x","article-title":"Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients","volume":"21","author":"Balch CM","year":"2014","unstructured":"Balch CM, Thompson JF, Gershenwald JE, et al.. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol. 2014, 21:1075-81. 10.1245\/s10434-013-3464-x","journal-title":"Ann Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07690-4","article-title":"Age and lymphovascular invasion accurately predict sentinel lymph node metastasis in T2 melanoma patients","volume":"26","author":"Egger ME","year":"2019","unstructured":"Egger ME, Stevenson M, Bhutiani N, et al.. Age and lymphovascular invasion accurately predict sentinel lymph node metastasis in T2 melanoma patients. Ann Surg Oncol. 2019, 26:3955-61. 10.1245\/s10434-019-07690-4","journal-title":"Ann Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0168","article-title":"Age-related changes in HAPLN1 increase lymphatic permeability and affect routes of melanoma metastasis","volume":"9","author":"Ecker BL","year":"2019","unstructured":"Ecker BL, Kaur A, Douglass SM, et al.. Age-related changes in HAPLN1 increase lymphatic permeability and affect routes of melanoma metastasis. Cancer Discov. 2019, 9:82-95. 10.1158\/2159-8290.CD-18-0168","journal-title":"Cancer Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1245\/aso.2004.04.015","article-title":"Correlation between prognostic factors and increasing age in melanoma","volume":"11","author":"Chao C","year":"2004","unstructured":"Chao C, Martin RC 2nd, Ross MI, et al.. Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol. 2004, 11:259-64. 10.1245\/aso.2004.04.015","journal-title":"Ann Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob JA","year":"2012","unstructured":"Jakob JA, Bassett RL Jr, Ng CS, et al.. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer. 2012, 118:4014-23. 10.1002\/cncr.26724","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0420-x","article-title":"Age-related lymphatic dysfunction in melanoma patients","volume":"16","author":"Conway WC","year":"2009","unstructured":"Conway WC, Faries MB, Nicholl MB, Terando AM, Glass EC, Sim M, Morton DL. Age-related lymphatic dysfunction in melanoma patients. Ann Surg Oncol. 2009, 16:1548-52. 10.1245\/s10434-009-0420-x","journal-title":"Ann Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2007.1023","article-title":"Senile changes in human lymph nodes","volume":"6","author":"Pan WR","year":"2008","unstructured":"Pan WR, Suami H, Taylor GI. Senile changes in human lymph nodes. Lymphat Res Biol. 2008, 6:77-83. 10.1089\/lrb.2007.1023","journal-title":"Lymphat Res Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0193","article-title":"Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility","volume":"9","author":"Kaur A","year":"2019","unstructured":"Kaur A, Ecker BL, Douglass SM, et al.. Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Cancer Discov. 2019, 9:64-81. 10.1158\/2159-8290.CD-18-0193","journal-title":"Cancer Discov"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/19.093","article-title":"Immunotherapy outcomes in advanced melanoma in relation to age","volume":"24","author":"Joshi K","year":"2020","unstructured":"Joshi K, Atwal D, Ravilla R, et al.. Immunotherapy outcomes in advanced melanoma in relation to age. Perm J. 2020, 24:3-7. 10.7812\/TPP\/19.093","journal-title":"Perm J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2695-2","article-title":"Melanoma brain metastases harboring BRAF (V600K) or NRAS mutations are associated with an increased local failure rate following conventional therapy","volume":"137","author":"Fang P","year":"2018","unstructured":"Fang P, Boehling NS, Koay EJ, et al.. Melanoma brain metastases harboring BRAF (V600K) or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol. 2018, 137:67-75. 10.1007\/s11060-017-2695-2","journal-title":"J Neurooncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007, 335:806-8. 10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2944","article-title":"Effect of age on melanoma risk, prognosis and treatment response","volume":"98","author":"Ribero S","year":"2018","unstructured":"Ribero S, Stucci LS, Marra E, et al.. Effect of age on melanoma risk, prognosis and treatment response. Acta Derm Venereol. 2018, 98:624-9. 10.2340\/00015555-2944","journal-title":"Acta Derm Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2015.02.001","article-title":"Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan","volume":"115","author":"Sheen YS","year":"2016","unstructured":"Sheen YS, Liao YH, Liau JY, Lin MH, Hsieh YC, Jee SH, Chu CY. Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan. J Formos Med Assoc. 2016, 115:121-7. 10.1016\/j.jfma.2015.02.001","journal-title":"J Formos Med Assoc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12910","article-title":"Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma","volume":"29","author":"Pracht M","year":"2015","unstructured":"Pracht M, Mogha A, Lespagnol A, et al.. Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma. J Eur Acad Dermatol Venereol. 2015, 29:1530-8. 10.1111\/jdv.12910","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.287","article-title":"Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma","volume":"111","author":"Carlino MS","year":"2014","unstructured":"Carlino MS, Haydu LE, Kakavand H, et al.. Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma. Br J Cancer. 2014, 111:292-9. 10.1038\/bjc.2014.287","journal-title":"Br J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136525-malignant-melanoma-in-older-adults-different-patient-or-different-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:46Z","timestamp":1707508726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136525-malignant-melanoma-in-older-adults-different-patient-or-different-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.34742","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,7]]}}}